Rani Therapeutics Holdings (RANI) Cash from Investing Activities (2020 - 2026)

Rani Therapeutics Holdings' Cash from Investing Activities history runs 7 years deep, the most recent figure standing at -$2.4 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 113.44% year-over-year to -$2.4 million; the TTM figure through Mar 2026 stood at -$27.7 million (down 199.87% YoY), while the FY2025 annual figure was -$7.0 million, down 135.49% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$2.4 million, up from -$31.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $18.2 million in Q1 2025, with the low at -$71.3 million in Q3 2022.
• The 5-year median for Cash from Investing Activities is $1.7 million (2023), against an average of -$2.0 million.
• The sharpest annual moves came in 2023 and 2025: Cash from Investing Activities soared 3004.6% in 2023, then tumbled 1328.56% in 2025.
• Rani Therapeutics Holdings' Cash from Investing Activities stood at -$457000.0 in 2022, then jumped by 3004.6% to $13.3 million in 2023, then plunged by 81.01% to $2.5 million in 2024, then sank by 1328.56% to -$31.0 million in 2025, then soared by 92.09% to -$2.4 million in 2026.
• Business Quant data shows RANI's Cash from Investing Activities at -$2.4 million in Q1 2026, -$31.0 million in Q4 2025, and $5.7 million in Q2 2025.